EBM — Eastwood Bio-Medical Canada Income Statement
0.000.00%
Last trade - 00:00- CA$30.31m
- CA$30.38m
- CA$0.70m
Annual income statement for Eastwood Bio-Medical Canada, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.718 | 0.981 | 1.3 | 0.868 | 0.702 |
| Cost of Revenue | |||||
| Gross Profit | 0.213 | 0.458 | 0.903 | 0.548 | 0.454 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.57 | 1.58 | 1.45 | 1.41 | 1.16 |
| Operating Profit | -0.854 | -0.604 | -0.15 | -0.547 | -0.456 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.852 | -0.604 | -0.15 | -0.547 | -0.456 |
| Net Income After Taxes | -0.852 | -0.604 | -0.15 | -0.547 | -0.456 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.852 | -0.604 | -0.15 | -0.547 | -0.456 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.852 | -0.604 | -0.15 | -0.547 | -0.456 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.014 | -0.009 | -0.002 | -0.008 | -0.006 |